Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celtic Catalysts is an Irish biotechnology and specialty chemical company that specializes in the development of chiral synthesis technologies. Founded in 2000 as a spin-out from University College Dublin, the company leverages proprietary P-chiral ligand technology to produce high-value enantiomerically pure intermediates and catalysts. These products and services primarily support the pharmaceutical and fine chemical industries in the development of complex small molecule drugs. The company's platform enables more efficient and cost-effective asymmetric synthesis processes, reducing waste and improving yield for drug manufacturers. In 2014, Celtic Catalysts was acquired by SESVanderHave, a global leader in the sugar beet seed industry, to enhance its internal research and development capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celtic Catalysts.